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Hepatoportal Venous Trauma: Analysis
of Incidence, Morbidity, and Mortality
Shelley Maithel, MD1 , Areg Grigorian, MD1, Nii-Kabu Kabutey, MD1,
Brian M. Sheehan, MD1, Sahil Gambhir, MD1, Ronald F.Wolf, MD1,
Zeljka Jutric, MD1, and Jeffry Nahmias, MD, MHPE1
Abstract
Objectives: Although traumatic injuries to the superior mesenteric vein (SMV), portal vein (PV), and hepatic vein (HV) are rare,
their impact is significant. Small single center reports estimate mortality rates ranging from 29% to 100%. Our aim is to elucidate
the incidence and outcomes associated with each injury due to unique anatomic positioning and varied tolerance of ligation. We
hypothesize that SMV injury is associated with a lower risk of mortality compared to HV and PV injury in adult trauma patients.
Methods: The Trauma Quality Improvement Program database (2010-2016) was queried for patients with injury to either the
SMV, PV, or HV. A multivariable logistic regression model was used for analysis. Results: From 1,403,466 patients, 966 (0.07%)
had a single major hepatoportal venous injury with 460 (47.6%) involving the SMV, 281 (29.1%) involving the PV, and 225 (23.3%)
involving the HV. There was no difference in the percentage of patients undergoing repair or ligation between SMV, PV, and HV
injuries (P > .05). Compared to those with PV and HV injuries, patients with SMV injury had a higher rate of concurrent bowel
resection (38.5% vs 12.1% vs 7.6%, P < .001) and lower mortality (33.3% vs 45.9% vs 49.3%, P < .01). After controlling for
covariates, traumatic SMV injury increased the risk of mortality (odds ratio [OR] 1.59, confidence interval [CI] ¼ 1.00-2.54,
P ¼ .05) in adult trauma patients; however, this was less than PV injury (OR ¼ 2.77, CI ¼ 1.56-4.93, P ¼ .001) and HV injury
(OR ¼ 2.70, CI ¼ 1.46-4.99, P ¼ .002). Conclusion: Traumatic SMV injury had a lower rate of mortality compared to injuries of
the HV and PV. SMV injury increased the risk of mortality by 60% in adult trauma patients, whereas PV and HV injuries nearly
tripled the risk of mortality.
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Introduction
Traumatic superior mesenteric vein (SMV), portal vein (PV),
and hepatic vein (HV) injuries represent rare yet devastating
injuries. Mortality rates are high for major hepatoportal
venous trauma, ranging from 29% to 83% for SMV,1-14
50% to 100% for PV,9-21 and 50% to 100% for HV inju-
ries9,22-27 in mostly single institution studies. Most deaths are
a result of exsanguination leading to hemorrhagic shock, with
many patients dying prior to arrival to the hospital.27 For
patients who undergo operative exploration, survival is often
difficult to achieve secondary to the complexity associated
with access and control of these injuries with some series
reporting 100% intraoperative mortality.11,13,21 Investigators
have reported that mortality of hepatoportal venous injuries is
associated with initial systolic blood pressure (SBP), injury
severity score (ISS), transfusion requirements, and presence
of additional injuries.3, 9,13,28
SMV, PV, and HV have unique anatomic positioning
and varied tolerance of ligation. As an example, while HVs
are one of the most difficult abdominal veins to expose,
ligation is often well tolerated because of the venous drai-
nage provided by the remaining two HVs.29,30 SMV inju-
ries are often easier to locate by exposing the vessel at the
root of the mesocolon, and prior studies have shown that
SMV ligation leads to less bowel ischemia and portal
hypertension compared to PV ligation.2,12,31 Sirinek et al5
reported that mortality of patients with SMV, PV, and HV
injuries was 25%, 100%, and 60% in a single institution
case series. We hypothesize that SMV injury is associated
with lower risk of mortality compared to PV and HV injury
in adult trauma patients.
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Methods
This work was deemed exempt by the institutional review board
of the University of California, Irvine, as it involved a deidenti-
fied national database. This study was a retrospective analysis
using the Trauma Quality Improvement Program (TQIP) data-
base, which currently includes over 850 trauma centers from all
50 states. The TQIP database was queried from January 2010 to
December 2016 to identify patients aged 18 years and older.
Patients with a single major hepatoportal venous injury, defined
as either a SMV, PV, or HV injury, were identified using the
International Classification of Diseases (ICD) Version-9 diag-
nosis codes: 902.31 for SMV, 902.33 for PV, and 902.11 for HV.
Patients with injuries to more than one major hepatoportal vein
were excluded. These 3 groups were then compared.
Patient demographic information including age, gender,
body mass index (BMI), and prehospital comorbidities was
collected as well as injury profile including lowest SBP within
24 hours, severe (grade > 3) abbreviated injury scale (AIS) for
body region, and ISS. Concomitant vascular and organ injuries
associated with each vessel injury were also compared. The
primary outcome was in-hospital mortality. Secondary out-
comes included total hospital length of stay (LOS), intensive
care unit LOS, ventilator days, requirement of exploratory
laparotomy or bowel resection, blood product transfusion, and
in-hospital complications. Additionally, percent of patients
with each injury undergoing venous ligation versus surgical
repair was classified using ICD procedure codes. Rates of mor-
tality and bowel resection associated with venous ligation ver-
sus surgical repair were compared. Descriptive statistics were
performed for all variables. Continuous data were reported as
means with standard deviation or medians with interquartile
range. The w2 and Fisher exact t test were used to compare
categorical variables between patients with either SMV, PV,
or HV injury. Kruskal-Wallis test was used for continuous
variables between patients with either SMV, PV, or HV injury.
A univariable logistic regression model was first used to find
the magnitude of association between predictor variables and
mortality. A hierarchical multivariable logistic regression model
was then used with covariates with statistical significance
(P .20), which included age > 65 years, male gender, hypoten-
sion (defined as SBP < 90) or tachycardia (defined as heart rate >
100) on admission, packed red blood cells (PRBCs)  6 units
given in 4 hours, obesity (defined as BMI  30), peripheral
vascular disease, chronic kidney disease, diabetes, smoker,
hypertension, chronic obstructive pulmonary disease, cerebro-
vascular accident, ISS  25, AIS > 3 in abdomen, thorax, head,
or spine, concomitant injuries to superior mesenteric artery
(SMA), inferior mesenteric artery, aorta, inferior vena cava
(IVC), liver, spleen, pancreas, stomach, small intestine, colon/
rectum, kidney, as well as development of acute kidney injury
and acute respiratory distress syndrome. The adjusted risk for
mortality was reported with an odds ratio (OR) and 95% confi-
dence intervals (CIs). The reference group used in our analysis
included all adult trauma patients to find the adjusted risk of
mortality of patients with SMV, PV, or HV injury compared
to those without SMV, PV, or HV injury, respectively. All
P-values were 2-sided, with a statistical significance level of
< .05. All analyses were performed with IBM SPSS Statistics
for Windows (version 24, IBM Corp, Armonk, New York).
Results
Demographics and Mortality in Adult Trauma
Patients with Major Hepatoportal Venous Injury
From 1,403,466 patients, 966 (0.07%) had a single major hepa-
toportal venous injury with 460 (47.6%) involving the SMV, 281
(29.1%) involving the PV, and 225 (23.3%) involving the HV.
Compared to patients with PV and HV injuries, those with SMV
injury were older (39 vs 21 vs 26 years, P < .001), with a higher
median BMI (29 vs 26 vs 26 kg/m2, P¼ .01) and a higher rate of
comorbidities such as diabetes mellitus (8.9% vs 3.6% vs 2.7%,
P ¼ .001) and hypertension (16.5% vs 6.8% vs 5.8%, P ¼ .001)
(Table 1). Patients with SMV injury had a lower mean ISS (22 vs
25 vs 29, P < .001), lower percentage of severe AIS for abdomen
(55.2% vs 68.3% vs 76.0%, P < .001), and higher median lowest
SBPwithin24hours (81vs73vs72mmHg,P¼ .01) compared to
those with PV and HV injuries. A higher percentage of SMV
injuries were from a blunt mechanism (61.3% vs 44.1% vs
55.1%, P < .001) compared to PV and HV injuries.
Mortality of major hepatoportal venous trauma was the fol-
lowing: 33.3% for SMV, 45.9% for PV, and 49.3% for HV.
SMV injury was associated with a lower mortality rate com-
pared to PV and HV injuries (P < .001).
Risk of Mortality Associated with Major
Hepatoportal Venous Trauma
Multivariable analysis of adult trauma patients revealed trau-
matic SMV injury increased risk of mortality (OR¼ 1.59, CI¼
1.00-2.54, P ¼ .05), although less so than PV injury (OR ¼
2.77, CI ¼ 1.56-4.93, P ¼ .001) and HV injury (OR ¼ 2.70, CI
¼ 1.46-4.99, P ¼ .002).
Secondary Outcomes in Adult Trauma Patients
with Major Hepatoportal Venous Injury
Compared to patients with PV and HV injuries, patients with
SMV injury required exploratory laparotomy more frequently
(67.4% vs 63.0% vs 56.9%, P ¼ .03) as well as bowel resection
(38.5% vs 12.1% vs 7.6%, P < .001). There was no difference for
in-hospital complications between SMV, PV, and HV injuries
(Table 2). While patients with SMV injury had longer LOS
compared to patients with PV and HV injuries (10 vs 7 vs 5
days, P ¼ .001); when comparing only patients who survived
hospitalization, the LOS was similar among patients with SMV,
HV, and PV injuries (P > .05). Patients with PV injury required
more median PRBC units within 24 hours compared to those
with SMV and HV injuries (18 vs 11 vs 12 units, P ¼ .01).
Vein ligation occurred at similar rates with 21.1% of SMV
injuries, 18.9% of PV injuries, and 16.4% of HV injuries
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(P > .05). Repair was required in 13.7% of patients with SMV
injury and was not significantly different than those with PV
(12.5%) or HV (16.4%) injury (P > .05). For those with SMV or
HV injury, repair versus ligation did not significantly change
the rates of bowel resection or mortality (P > .05). For those
with PV injury, ligation resulted in a higher mortality compared
to repair (71.4% vs 45.3%, P ¼ .02) but did not affect the rate
of bowel resection (P > .05).
Concomitant Injuries in Adult Trauma Patients with
Major Hepatoportal Venous Injury
Compared to patients with PV and HV injuries, patients with
SMV injury had a higher incidence of concomitant injuries of
the SMA (21.7% vs 3.6% vs 2.7%, P < .001), aorta (8.3% vs
3.6% vs 4.4%, P ¼ .02), small intestine (52.0% vs 24.9% vs
13.3%, P < .001), and colon/rectum (36.5% vs 17.8% vs 12.9%,
Table 2. Clinical Outcomes in Adult Trauma Patients With Major Hepatoportal Venous Injury.
Outcome SMV, n ¼ 460 Portal Vein, n ¼ 281 Hepatic Vein, n ¼ 225 P Value
LOS overall, days, median (IQR) 10 (18) 7 (17) 5 (14) .001
LOS, alive patients only, days, median (IQR) 16 (21) 16 (21) 12 (21) .25
ICU, days, median (IQR) 6 (12) 5 (11) 5 (9) .31
Ventilator, days, median (IQR) 3 (10) 3 (8) 3 (6) .55
PRBC units within 24 hours, median (IQR) 11 (18) 18 (24) 12 (28) .01
Required ex lap, n (%) 310 (67.4%) 177 (63.0%) 128 (56.9%) .03
Required bowel resection, n (%) 177 (38.5%) 34 (12.1%) 17 (7.6%) <.001
Complications, n (%)
Acute kidney injury 40 (8.7%) 22 (7.8%) 14 (6.2%) .53
Acute renal failure 1 (0.1%) 0 (0.0%) 0 (0.0%) .58
Deep vein thrombosis 23 (5.0%) 18 (6.4%) 15 (6.7%) .60
Pulmonary embolism 13 (2.8%) 9 (3.2%) 5 (2.2%) .80
ARDS 28 (6.1%) 14 (5.0%) 7 (3.1%) .25
Pneumonia/VAP 55 (12.0%) 23 (8.2%) 21 (9.3%) .23
Mortality, n (%) 153 (33.3%) 129 (45.9%) 111 (49.3%) <.001
Days to death, days, median (IQR) 1 (1) 1 (0) 1 (0) .38
Abbreviations: ARDS, acute respiratory distress syndrome; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; PRBC, packed red blood cell;
SMV, superior mesenteric vein; VAP, ventilator associated pneumonia.
Table 1. Demographics of Adult Trauma Patients With Major Hepatoportal Venous Injury.
Characteristics SMV, n ¼ 460 Portal Vein, n ¼ 281 Hepatic Vein, n ¼ 225 P Value
Age, year, median (IQR) 39 (29) 31 (25) 26 (18) <.001
Male, n (%) 354 (77.0%) 207 (73.7%) 167 (74.2%) .54
ISS, mean (SD) 22 (16) 25 (16) 29 (16) <.001
Lowest SBP within 24 hours, in mm Hg, median (IQR) 81 (36) 73 (34) 72 (41) .01
BMI, median (IQR) 29 (10) 26 (7) 26 (7) .01
Comorbidities, n (%)
Peripheral vascular disease 1 (0.2%) 0 (0.0%) 0 (0.0%) .58
Congestive heart failure 7 (1.5%) 0 (0.0%) 0 (0.0%) .02
End-stage renal disease 2 (0.4%) 0 (0.0%) 0 (0.0%) .33
Smoker 58 (12.6%) 41 (14.6%) 33 (14.7%) .66
Diabetes 41 (8.9%) 10 (3.6%) 6 (2.7%) .001
Hypertension 76 (16.5%) 19 (6.8%) 13 (5.8%) .001
COPD 22 (4.8%) 13 (4.6%) 4 (1.8%) .14
Cerebrovascular accident 2 (0.4%) 1 (0.4%) 1 (0.4%) .98
Mechanism of injury, n (%)
Blunt 282 (61.3%) 124 (44.1%) 124 (55.1%) <.001
Penetrating 175 (38.0%) 157 (55.9%) 99 (44.0%) <.001
Others 3 (0.7%) 0 (0.0%) 2 (0.9%) <.001
AIS (grade > 3), n (%)
Spine 9 (2.0%) 10 (3.6%) 6 (2.7%) .41
Thorax 70 (15.2%) 33 (11.7%) 48 (21.3%) .01
Abdomen 254 (55.2%) 192 (68.3%) 171 (76.0%) <.001
Lower extremity 12 (2.6%) 4 (1.4%) 7 (3.1%) .42
Abbreviations: AIS, abbreviated injury scale; BMI, body mass index; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; ISS, injury severity
score; SBP, systolic blood pressure; SD, standard deviation; SMV, superior mesenteric vein.
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P < .001), and lower incidence of injuries to the IVC (8.9% vs
19.6% vs 19.6%, P < .001) and liver (31.1% vs 77.2% vs
85.3%, P < .001). Compared to those with SMV and PV inju-
ries, patients with HV injury had a lower incidence of injuries
to the pancreas (4.9% vs 14.8% vs 14.6%, P < .001) and sto-
mach (6.2% vs 12.8 vs 15.7%, P ¼ .004) (Table 3).
Concomitant injuries were included in the multivariable
regression model and the concomitant injuries that most signifi-
cantly increased the risk of mortality was similar among SMV,
HV, and PV injuries and included IVC injury, SMA injury, pan-
creatic injury, aortic injury, and small intestine injury (Table 4).
Discussion
This study is the first to report demographics and patient out-
comes on individual major hepatoportal venous traumatic inju-
ries in a large cohort of patients nationwide. The results of this
study confirmed our hypothesis that SMV injury is associated
with a lower rate of mortality in adult trauma patients com-
pared to PV and HV injuries. Traumatic SMV, PV, and HV
injuries are all independent predictors of mortality. In support
of our hypothesis, SMV traumatic injury is associated with a
lower risk of mortality as it only increased risk of mortality by
60%, whereas HV and PV injuries nearly tripled the risk of
mortality.
The results of our study are consistent with prior case series
that have demonstrated traumatic SMV injury to have a lower
mortality rate compared to PV and HV injuries.5,32 A possible
explanation for this is that a lower percentage of patients with
SMV injury had IVC injury compared to those with PV and HV
injuries in our study and we found IVC injuries to nearly triple
the associated risk of mortality. This is further supported by
Asensio et al, who demonstrated that of all abdominal venous
injuries, IVC injury was associated with the highest mortality
(75%-100%).10 Another possible explanation is that SMV liga-
tion is better tolerated than PV ligation. We found that a similar
Table 3. Concomitant Injuries Associated With Major Hepatoportal Venous Injury in Adult Trauma Patients.
Concomitant injury SMV, n ¼ 460 Portal Vein, n ¼ 281 Hepatic Vein, n ¼ 225 P Value
Vascular injury, n (%)
Celiac artery 7 (1.5%) 1 (0.4%) 2 (0.9%) .31
Superior mesenteric artery 100 (21.7%) 10 (3.6%) 6 (2.7%) <.001
Inferior mesenteric artery 3 (0.7%) 0 (0.0%) 0 (0.0%) .19
Aorta 38 (8.3%) 10 (3.6%) 10 (4.4%) .02
Inferior vena cava 41 (8.9%) 55 (19.6%) 44 (19.6%) <.001
Organ injury, n (%)
Liver 143 (31.1%) 217 (77.2%) 192 (85.3%) <.001
Spleen 103 (22.4%) 56 (19.9%) 52 (23.1%) .64
Pancreas 68 (14.8%) 41 (14.6%) 11 (4.9%) <.001
Stomach 59 (12.8%) 44 (15.7%) 14 (6.2%) .004
Small intestine 239 (52.0%) 70 (24.9%) 30 (13.3%) <.001
Colon/rectum 168 (36.5%) 50 (17.8%) 29 (12.9%) <.001
Kidney 68 (14.8%) 48 (17.1%) 34 (15.1%) .69
Abbreviation: SMV, superior mesenteric vein.
Table 4. Risk of Mortality Associated With Concomitant Injuries in Patients With Single Major Hepatoportal Venous Injury in Adult Trauma
Patients.
Concomitant Injury SMV, n ¼ 460 Portal Vein, n ¼ 281 Hepatic Vein, n ¼ 225
Vascular injury, OR (CI)
Celiac artery 1.17 (0.78-1.78) 1.16 (0.77-1.76) 1.17 (0.78-1.78)
Superior mesenteric artery 1.61 (1.16-2.24) 1.67 (1.20-2.31) 1.69 (1.22-2.34)
Inferior mesenteric artery 0.61 (0.24-1.59) 0.61 (0.24-1.59) 0.61 (0.24-1.58)
Aorta 1.31 (1.17-1.47) 1.31 (1.17-1.47) 1.31 (1.17-1.47)
Inferior vena cava 2.70 (2.14-3.41) 2.65 (2.10-3.35) 2.63 (2.08-3.32)
Organ injury, OR (CI)
Liver 0.99 (0.93-1.05) 0.99 (0.93-1.05) 0.99 (0.93-1.05)
Spleen 0.81 (0.76-0.86) 0.81 (0.76-0.86) 0.81 (0.76-0.86)
Pancreas 1.50 (1.15-1.96) 1.49 (1.15-1.95) 1.52 (1.16-1.98)
Stomach 0.96 (0.80-1.15) 0.95 (0.79-1.15) 0.96 (0.80-1.16)
Small intestine 1.13 (1.02-1.26) 1.14 (1.02-1.27) 1.14 (1.03-1.27)
Colon/rectum 0.95 (0.85-1.07) 0.96 (0.86-1.07) 0.96 (0.86-1.07)
Kidney 0.70 (0.65-0.77) 0.70 (0.65-0.77) 0.70 (0.65-0.77)
Abbreviations: CI, confidence interval; OR, odds ratio; SMV, superior mesenteric vein.
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proportion of patients with SMV and PV injuries undergo liga-
tion, and prior studies have suggested that SMV ligation is
better tolerated. While there is a concern for possible bowel
necrosis, Donahue and Strauch33 found that SMV ligation had
less morbidity and mortality compared to PV ligation due to
continued venous drainage of the bowel via the inferior mesen-
teric vein and portosystemic collaterals. In further support,
Stone et al12 found that SMV ligation had a mortality of 67%
while PV ligation had a mortality of 88%, and Coimbra et al14
found that SMV ligation had a mortality of 50% while PV
ligation had a mortality of 100%. Our study supports these prior
single institution series as we show SMV injury has a similar
rate of ligation to PV injury yet lower overall mortality. Addi-
tionally, our study showed that the rates of mortality were not
significantly different between SMV ligation and repair. This
finding can be used to guide surgeons and we recommend
consideration of ligation of the SMV as a potential means of
salvage in a hemodynamically unstable and exsanguinating
patient.
On the other hand, injury to the PV is especially trouble-
some as it supplies the majority of blood flow to the liver. We
found that traumatic PV injury is associated with the highest
risk for mortality among hepatoportal venous trauma. This can
be expected as the PV has a blood flow rate of 1 L/min, leading
to death secondary to exsanguination when injured.17 This is
supported by our study, in which patients with PV injury
required 40% more blood transfusions than those with SMV
or HV injury. Another possible explanation is that ligation of
the PV is less tolerated than ligation of SMV and HV injuries.
This finding has been demonstrated in multiple other studies
including some series, which demonstrated a mortality of 100%
with PV ligation.11,18-21 However, Sabat et al recently per-
formed an analysis of the National Trauma Data Bank and
found PV ligation had a mortality rate of 59.2% and ligation
of PV did not increase the risk of mortality compared to repair
on multivariable analysis.17 Our study found that PV ligation
increased the rate of mortality compared to PV repair; however,
this was only in a bivariate comparison as the sample size was
not large enough to support a multivariable regression model
and we could not control for patient and intraoperative factors.
Therefore, the higher rate of mortality associated with ligation
versus repair of PV in our study may simply reflect selection
bias. Currently, not enough evidence exists to support ligation
of PV. Future studies are needed to determine what specific
factors, such as time to operating room, type of vascular injury,
and intraoperative physiology, lead to the ideal setting for
repair versus ligation to help lower mortality of this highly
lethal injury.
While many studies have reported that the majority of
hepatoportal venous injuries are from penetrating mechan-
isms, we found that just over half of hepatoportal venous
injuries were from blunt mechanisms.1,10 Coimbra et al’s
study from 1987 to 2006 showed that SMV and PV injuries
occurred from a blunt mechanism only 27% of the time. Addi-
tionally, they showed mortality from blunt compared to pene-
trating trauma for SMV was 57.0% vs 37.5%, with cause of
mortality being hemorrhage in 92% of patients.14 One poten-
tial explanation for the increase in blunt hepatoportal venous
trauma is the widespread adoption of massive transfusion
protocols (MTPs), which allow for blunt trauma patients who
may have previously died from exsanguination prior to reach-
ing the operating room to survive to diagnosis of the hepato-
portal venous injury. Most prior reports on hepatoportal
venous trauma are before the widespread implementation of
MTPs.34 Furthermore, Dente et al35 showed that the imple-
mentation of a MTP at their institution increased the survival
of blunt trauma patients from 44% to 55% but had no effect on
survival of penetrating trauma patients. Additionally,
improved trauma systems including shorter prehospital trans-
port times and expeditious access to an operating room may
allow for the subset of blunt hepatoportal venous trauma
patients who previously would have died at the scene to sur-
vive until hospital diagnosis. This is supported by Ball et al36
who demonstrated that shorter hospital time was associated
with a 34% increase in total number of abdominal vascular
injuries received by their trauma center. Future research is
needed focusing on management techniques specific for blunt
hepatoportal venous trauma as the incidence is rising and
brings unique challenges not present in penetrating vascular
trauma.
Limitations to this analysis include those inherent to a retro-
spective database such as reporting bias, coding error, and
missing data. In addition, we are restricted to data fields avail-
able in the TQIP database and were unable to assess the exact
injury characteristics (ie, American Association for the Surgery
of Trauma grade), as well as the specific location of injury (ie,
intra versus extra parenchymal HV and retropancreatic SMV,
etc) and the patients intraoperative hemodynamic status, which
would impact treatment and mortality. Furthermore, informa-
tion regarding the use of intravascular shunting and concomi-
tant assistance of a vascular and/or hepatobiliary surgeon is not
available within TQIP. Finally, TQIP is confined to index hos-
pitalization outcomes, thus no information regarding long-term
outcomes are available. Despite these limitations, our study
provides a large contemporary experience from trauma centers
across the country making the results more generalizable.
Conclusion
Compared to injuries of the PV and HV, traumatic SMV injury
is associated with nearly 12% decreased absolute rate of mor-
tality. Furthermore, traumatic PV and HV injuries are associ-
ated with a nearly tripled increase in mortality in adult trauma
patients, while SMV injury only increased the risk of mortality
by 60%. Mortality rates did not differ between SMV ligation
and SMV repair, which suggest that SMV ligation can be tol-
erated in exsanguinating patients where no other options exist.
The significant morbidity and mortality we found to be asso-
ciated with these injuries can help guide clinicians when speak-
ing to patients and their families about treatment strategies and
prognosis.
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